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vanced HIV-1 disease (Ho et al., 1995; Wei et al., 1995;Division of Endocrinology and Metabolism
Perelson et al., 1996, 1997); the large number of viralUniversity of California, San Francisco
quasispecies present in individuals with HIV-1 infection²Department of Nutritional Sciences
and the rate of emergence of drug-resistant viral strainsUniversity of California, Berkeley
during the progression of disease and after the initiationBerkeley, California 94720
of antiretroviral therapy (Coffin, 1992, 1995; Ho et al.,³Gladstone Institute of Virology and Immunology
1995; Wain-Hobson, 1995; Wei et al., 1995; Perelson et§Department of Medicine
al., 1996); and the prognostic value of the plasma viralSan Francisco General Hospital
load for predicting the rate of decrease in CD41 T cellDivision of AIDS
counts and the rate of progression to aquired immuno-University of California, San Francisco
deficiency syndrome (AIDS) (Mellors et al., 1995, 1996;San Francisco, California 94110
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The predictions suggested by this model have far-University of California, San Francisco
reaching implications for both theoretical views aboutSan Francisco, California 94143
and therapeutic approaches toward HIV-1 disease. It is
posited that absolute CD41 T cell turnover rates are high
early in the course of HIV-1 disease when CD41 T cellA powerful ªhigh turnoverº model of human immunodefi-
counts are normal and that CD41 T cell turnover corre-ciency virus type 1 (HIV-1) immunopathogenesis has
lates with plasma viral load. It follows that the mainbeen developed over the past several years (Coffin,
impact of HAART will be to slow the rate of cell de-1995; Ho et al., 1995; Wain-Hobson, 1995; Wei et al.,
struction.1995; Perelson et al., 1996, 1997). This model differs
Intuitively, this conceptual framework makes sense,from previous concepts of HIV-1 disease in its emphasis
but its predictions are based on several assumptionson the dynamic and quantitative aspects of HIV-1 and
that remain unsupported by direct experimental proof.lymphocyte behavior. It has deservedly received great
First, it assumes that changes in circulating CD41 Tattention because it attempts to answer the central para-
cell numbers represent changes in whole-body T celldox of HIV-1 disease: the collapse of the immune system
turnover rather than changes in T cell distribution be-despite an apparently small number of infected target
tween blood and tissues. Several workers (Dimitrov andcells. The model also has profound therapeutic implica-
Martin, 1995; Mosier, 1995; Sprent and Tough, 1995)tions with respect to strategies by which viral resistance
have pointed out that ªviral trapping,º hormones ofmay be avoided, the possible value of early intervention,
stress, or other factors could alter the distribution ofand the logic of immunostimulants.
lymphocytes between lymphoid organs and the periph-Here, we review the basic assumptions of this model
eral circulation. If antiviral therapy results in a changeand its underlying experimental evidence. We discuss
in T cell distribution, inferences about turnover wouldaspects of T lymphocyte turnover in HIV-1 disease that
not be justified from measurements of circulating T cellare not explained by the model and propose an alterna-
numbers alone.tive way to think about them. Finally, we suggest some
Second, the model assumes that rising CD41 T cellexperiments to refine our exploration of key but unre-
counts associated with HAART (Ho et al., 1995; Wei etsolved questions about T cell dynamics in HIV-1 disease.
al., 1995; Perelson et al., 1996) reflect a decreased rate of
cell destruction (lower turnover) rather than an increasedThe Accelerated Destruction (High Turnover)
rate of cell production. Since HIV-1 infection has adverseModel of CD41 T Cell Depletion
effects on central hematopoietic organs (e.g., bone mar-The high turnover model of CD41 T cell depletion has
row and thymus) (McCune, 1991; McCune and Kane-been developed by groups led by Ho (Ho et al., 1995;
shima, 1995), the rate of CD41 T cell production priorPerelson et al., 1996, 1997) and Shaw (Wei et al., 1995)
to antiretroviral therapy need not be identical to thatand has been elaborated by Coffin (1995), Wain-Hobson
found after therapy. Indeed, if effective antiretroviral
(1995), and others. Its central assertions are that HIV-1
therapy facilitates the production of peripheral CD41 T
induces CD41 T cell destruction at a very high rate (i.e.,
cells, the production rate before therapy may be lower.
1±2 3 109 cells/day) and that the resulting demand on
Third, the model assumes that the kinetics of cell and
CD41 T cell proliferation ultimately results in collapse
viral turnover observed in late disease can be extrapo-
of the immune system. Accordingly, it places virus-
lated to early disease. However, lymphopenic states
induced CD41 T cell destruction as the central event in
have previously been correlated with prolonged survival
HIV-1 immunopathogenesis.
and a tendency for marked clonal expansion of the re-
This model is based on several lines of evidence,
maining lymphocyte pool (Rocha et al., 1983; Miller and
Stutman, 1984; Rocha, 1987; Freitas and Rocha, 1993;
Tough and Sprent, 1995). Hence, the turnover of CD41#To whom correspondence should be addressed (e-mail: mike_
mccune.givi@quickmail.ucsf.edu). T cells in the lymphopenic late stage of disease may
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not be equivalent to that found early on, when the CD41 population is high. Indeed, the absence of any TRF
shortening in CD41 T cells from HIV-1±seropositive sub-T cell pool is relatively normal in size and composition.
Likewise, the viral turnover rate in early disease may be jects (Wolthers et al., 1996; Palmer et al., 1997) could
simply reflect preferential, HIV-1±mediated destructiondissimilar from that found in late-stage disease, if only
because the activation status of CD41 T cells usually of proliferating CD41 T cells. The TRF results thus do
not exclude any model of HIV-1 pathogenesis: the abso-differs between these two extremes (Liu et al., 1996). It
may therefore be misleading to extrapolate kinetic re- lute rate of CD41 T cell production in the body could
be high, low, or normal.sults about lymphocytes or viral turnover from one end
of the disease spectrum to the other.
Finally, the high turnover model assumes that normal
The Effect of HIV-1 Diseaserates of CD41 T cell turnover are known, for comparison
on T Cell Subpopulationsto rates in HIV infection (Michie et al., 1992; McLean
As recently reviewed by Mackall et al. (1997a), T celland Michie, 1995; Mackall et al., 1997a, 1997b). In fact,
populations inadvanced HIV-1 disease share severalchar-there are almost no reliable data regarding lymphocyte
acteristics with athymic peripheral expansions found indynamics (or even the size of the T cell pool) in healthy,
other settings: depletion of naive relative to memory Tuninfected humans (see below).
cell subsets; restricted diversity of the T cell receptorIn sum, there is little or no basis for the conclusion
(TCR) repertoire; a greater proportionof CD81 comparedthat chronic demand on the T cell production system is
with CD41 T cells; low CD41 T cell number; and reducedgreatly elevated above normal levels in HIV-1 infection,
functional competence of the T lymphocyte system. Al-thereby taxing the proliferative reserve of the immune
though the high turnover model has focused primarilysystem (the ªopen drainº model [Ho et al., 1995]). In fact,
on changes in total CD41 T cell numbers, these featuresrecent studies (Wolthers et al., 1996; Palmer et al., 1997)
of HIV-1±associated Tcell pathology require explanationhave failed to provide evidence for increased CD41 T
as well.cell turnover during the course of HIV-1 disease. These
Early depletion of thymus-derived naive (CD45RA1studies have used an indirect method for assessing cell
CD62L1) CD41 and CD81 T cells is a fundamental featurereplication: measurement of telomeric terminal restric-
of HIV-1 infection (Rabin et al., 1995; Roederer, 1995;tion fragment (TRF) length as an index of replicative
Roederer et al., 1995). Since these cells are resistant tohistory. This approach does not provide a definitive an-
productive infection by HIV-1 (Schnittman et al., 1990;swer to the question; if anything, it underscores the
Roederer et al., 1997; Woods et al., 1997), it is unlikelycurrent limitations in measuring lymphocyte dynamics
that they are being destroyed by direct viral infection.in vivo.
It is possible instead that they are not being producedÐThe TRF method is based on the observation that
that is, that thymic failure is a primary pathologic lesioneach round of cell division results in loss of telomeric
in HIV-1 disease. Several lines of evidence are consis-sequence due to the inability of DNA polymerase to
tent with this view. First, a variety of studies in humanreplicate completely the 59 end of the chromosome.
subjects (Seemayer et al., 1984; Grody et al., 1985; JoshiCells that have progressed through many mitoses ex-
and Oleske, 1985; Savino et al., 1986; Schuurman et al.,hibit a greater degree of TRF shortening than do those
1989; Burke et al., 1995) and in animal models (Baskinthat have divided less often. Wolthers et al. (1996) com-
et al., 1991; Li et al., 1992; Aldrovandi et al., 1993; Bony-pared TRF lengths over time in CD41 and CD81 T cell
hadi et al, 1993; Stanley et al., 1993; Beebe et al., 1994;populations from HIV-1±seropositive and HIV-1±sero-
Dua et al., 1994; Joag et al., 1996) indicate that thenegative subjects, and Palmer et al. (1997) compared
thymus is a target organ for lentiviral (including HIV-1)TRF lengths in these cell populations from HIV-1±
infection, with resultant destruction of intrathymic T pro-discordant monozygotic twins. In both studies, TRF
genitor cells (McCune, 1991; Su et al., 1995). Second,lengths inCD41 Tcells from HIV-1±seropositive subjects
there is a striking correlation between age and bothtended to be longer than in CD81 T cells from the same
thymic function and rates of HIV-1 disease progression.individual; in the study by Palmer et al., TRF lengths
During early life, intrauterine infection of the thymusin CD41 T cells from HIV-1±seropositive donors were
may effectively result in thymic aplasia (McCune, 1991).actually longer than those found in HIV-1±seronegative
Children born with phenotypic evidence of such ªthymictwins. These results clearly document differential popu-
failureº (i.e., the loss of naive CD41 and CD81 T cells inlation dynamics of CD41 and CD81 T cells in HIV-1±
the peripheral circulation) progress more rapidly to AIDSinfected subjects and could be interpreted to mean that
and to death (Kourtis et al., 1996). Likewise, older agethe turnover of CD41 T cells is equivalent to, or even
at the time of HIV-1 infection is one of the most importantslower than, that found in HIV-uninfected subjects.
determinants of disease progression rate in adults, aThe problem with this approach is that it cannot ac-
correlation that may be related to the fact that thymiccount for T cells that have been destroyed. If proliferat-
reserves diminish with age (Darby et al., 1996). In thising target cells are destroyed (Gowda et al., 1989), a
regard, the effects of HIV-1 infection may be analogoussampling bias is introduced for quiescent (nondividing)
to findings in the period following cytoreductive therapycells, which, by definition, have a stable TRF length.
for neoplastic disorders (Leino et al., 1991; Mackall etBecause of this sampling bias, TRF length in the surviv-
al., 1994, 1997a, 1997b), in which recovery of naive Ting CD41 T cell pool may not accurately reflect the repli-
cells occurs primarily in children and only rarely, if atcative history of the entire pool, and the average TRF
all, in adults. From this perspective, HIV-1±mediatedlength in a given cell population may not change, even
though the destruction rate of proliferating cells in the destruction of the thymus would remove a potentially
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important source of naive T cell production, resulting in Restricted TCR repertoire diversity indicates that the
CD41 T cell pool has expanded from a limited numbera disease of lower, and not higher, T cell turnover.
Alternative explanations for the loss of naive T cells of clonotypes. Accelerated destruction of T cells will
hasten the evolution of TCR repertoire restriction butinclude the possibilities that they may have a shorter
life span in the peripheral circulation or that they are cannot lead to this outcome by itself; a disorder of de
novo T cell generation must also be present. Since thebeing induced to differentiate at a greater rate than nor-
mal. Thus, HIV-1 infection may effectively remove or thymus is the dominant organ for the generation of TCR
diversity, this observation implies that a major lesion inrender dysfunctional those signals necessary for the
survival of naive cells (e.g., those mediated by major late-stage disease may reside at the level of thymic
maturation and production.histocompatibility complex class II antigens in the case
of naive CD41 T cells) (Takeda et al., 1996; Rooke et
al., 1997). Alternatively, HIV-1±mediated destruction of An Alternative Model of HIV-1±Induced T Cell
Dynamics: Regenerative Failuremore mature memory CD41 T cells may drive acceler-
ated maturation through the naive CD41 T cell pool. In In its current formulation (Ho et al., 1995), the high turn-
over model postulates that CD41 T cell homeostasiseither scenario, naive T cells would not be destroyed
by HIV-1 per se but instead would be lost by attrition successfully maintains total T cell numbers for several
years after HIV-1 infection, after which proliferative re-or simply by maturation.
Another feature of T lymphopoiesis in HIV-1 disease serves fail. The ultimate failure of T cell homeostasis is
therefore considered to be a late and not-unexpectedis the marked alterations in various subpopulations of
CD81 T cells, including a late decrease in memory CD81 exhaustion of physiologic reserve rather than a primary
pathologic event. As noted above, true T cell prolifera-T cell number as well as an early depletion of naive
CD81 T cells (Meyaard et al., 1994; Rabin et al., 1995; tion and destruction rates have not been measured in
either HIV-1±seropositive patients or ±seronegative con-Roederer et al., 1995). These changes are not easily
accomodated by a model that is focused on the destruc- trol subjects. Even if one accepts the indirect estimates
upon which the high turnover model is based, kinetiction of CD41 T cells. It is possible that CD81 T cells are
infected and destroyed by a non-CD4 mechanism, as analysis suggests a more profound failure of T cell ho-
meostasis than is currently postulated.suggested by Livingstone et al. (1996) and as observed
both in vitro and in vivo in animal models of HIV-1 infec- This point is exemplified by comparison of published
CD41 T cell proliferation rates in subjects who are HIV-tion (Stanley et al., 1993). It is also possible that CD81
T cell loss, like CD41 T cell loss, is the result of thymic 1±seronegative or who have advanced HIV-1 disease
(Table 1). These estimates indicate that the absolutefailure. CD41 and CD81 T cell lineages diverge relatively
late in thymopoiesis and, in principle, HIV-1 may infect number of CD41 T cells produced and destroyed per
day in persons with advanced HIV-1 disease (1±2 3 109and destroy both intrathymic T progenitor cells (CD32
CD41CD82) and double-positive thymocytes (CD31CD41 cells/day) (Ho et al., 1995; Wei et al., 1995; Perelson et
al., 1996, 1997) is not very different from the estimatedCD81) (McCune, 1991; Su et al., 1995). The targeting of
such progenitor cells would short circuit the production rate found in healthy control subjects (0.8 3 109 cells/
day) (Michie et al., 1992; McLean and Michie, 1995).of both CD41 and CD81 naive T cells.
Extrathymic CD81 T cell regeneration may then ex- These calculations therefore do not suggest that ad-
vanced HIV-1 disease is a true high turnover state forplain why an imbalance of total CD81 T cells compared
with CD41 T cells (more CD81 than CD41) is a consistent CD41 T cells, that is, one with higher rates of production
and destruction. Instead, the most striking kinetic fea-feature of HIV-1 infection. Mackall et al. (1997b) and
Heitger et al. (1997) have reported that nonthymic (pe- ture of advanced HIV-1 disease, if we accept the kinetic
profile following HAART as representing basal kinetics,ripheral) regenerative pathways are available for CD81
T cells following cytoreductive therapy in HIV-1±sero- is the much higher fraction of CD41 T cells lost per
day: the fractional destruction or replacement rate (Kdnegative adults. The naive CD81 T cells generated by
extrathymic pathways are restricted in function, how- in Table 1) is 10 times higher in patients with AIDS com-
pared with healthy control individuals.ever, and are identifiable phenotypically (CD571CD282)
(Gorochov et al., 1994; Posnett et al., 1994). If this path- A second important feature of the kinetics of ad-
vanced HIV-1 disease is the failure of the lymphohema-way explains the early predominance of CD81 T cells in
HIV-1 disease, it could be predicted that CD81 T cell topoietic system to increase the absolute CD41 T cell
regeneration rates despite 5- to 10-fold smaller CD4phenotypic diversity might be restricted even when the
CD81 T memory cell number is high. The late decrease pool size. This failure leads us to focus more on the
opposite side of T cell dynamics in late-stage HIV-1in memory CD81 T cells would then represent a loss of
this extrathymic pathway. The observation of greater disease: the failure of T cell regeneration (Figure 1). A
critical distinction between this view and the high turn-numbers of CD81 than CD41 T cells in HIV-1 infection
is again consistent with athymic peripheral expansion as over model is that it places emphasis on the failure of
T cell production as a primary pathogenic event rathera general state; accelerated destruction (high turnover)
need not be invoked. than on an exuberance of T cell destruction. It specifies
that the sources of production (e.g., the bone marrowFinally, the TCR repertoire of both CD41 and CD81 T
cells is restricted in advanced HIV-1 disease (Clerici et or thymus) are rendered dysfunctional in later stages of
HIV-1 disease, resulting in low rates of replacement inal., 1989; Rebai et al., 1994; Connors et al., 1997), an
observation that is not consistent with escape of existing the face of continued HIV-1 T cell destruction. This im-
balance ultimately leads to a decrease in the total-bodyCD41 T cells from random viral-mediated destruction.
Immunity
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Table 1. Quantitative Estimates of T Cell Dynamics in Humans: Comparison of HIV-1±Seronegative Subjects to Patients with Advanced
HIV-1 Disease
t1/2 Absolute Turnover
Subjects Cell Type Total CD4 Pool Size (no. of cells) Kd (d21) (days) Rate (cells/day)
HIV-1 seronegative Naive CD4 50% 1011 ,0.001 1200 z108
Memory CD4 50% 1011 z0.007 100 z7 3108
Total CD4 Ð 2 3 1011 0.004 170 z0.8 3 109
Advanced HIV-1 disease Naive CD4 z25% z1010 NA NA Ð
Memory CD4 z75% z2±4 3 1010 z0.05±0.10 7±14 z2 3 109
Total CD4 Ð z2±4 3 1010 0.05±0.10 7±14 z2 3 109
Kd, fractional destruction rate constant; t1/2, half-life. Kinetic estimates in HIV-1±seronegative subjects were based on the rate of loss of
unstable chromosome abnormalities following x-ray therapy (Michie et al., 1992; McLean and Michie, 1995); the proportions of naive and
memory cells are as reported elsewhere (Rabin et al., 1995; Roederer et al., 1995). Absolute turnover rate was calculated as pool size 3 Kd;
naive and memory CD4 pools were calculated separately and summed for the total rate. Kinetic estimates in advanced HIV-1 disease were
from Ho et al. (1995) and Wei et al. (1995), based on the rate of blood CD41 T cell accumulation after initiation of HAART. The turnover
calculation was as follows (Ho et al., 1995; Wei et al., 1995; Perelson et al., 1996): 18 cells/ml/day 3 106 ml/liter 3 5 liters blood volume 3 50,
where 50 corrects for the CD41 T cell distribution outside of blood. Kd is calculated as the turnover rate divided by the pool sizeÐfor example,
(7 3 108)/(1011) 5 0.007 day21 for memory CD41 T cells in HIV-1±seronegative subjects. The t1/2 is then equal to 0.69/Kd, assuming an exponential
replacement model. In subjects with HIV-1 disease, Kd and t1/2 estimates depend somewhat upon the model assumed (exponential or linear
increase) (Ho et al., 1995; Wei et al., 1995; Perelson et al., 1996); since CD41 T cell pool size increases during therapy, fractional replacement
rates are higher at baseline than on average, if a linear model is assumed.
The range of kinetic estimates (using either model) is therefore shown in the table. The proportions of naive and memory cells in advanced
HIV-1 disease are from Roederer et al. (1995). Since most CD41 T cells are memory cells in late-stage HIV-1 disease, memory CD41 T cell
turnover is assumed to be roughly identical to total CD41 T cell turnover in this calculation. The pool size in advanced HIV-1 disease was
calculated assuming blood CD41 T cell counts of 100±200 cells/ml and a proportional reduction in the whole-body CD41 T cell pool.
pool of mature T cells and to immune system collapse, number of fundamental therapeutic implications. For ex-
ample, if it is important only to suppress the destructionwhether or not the destruction rate of CD41 T cells is
accelerated (i.e., whether or not turnover is high). Rela- of mature CD41 T cells, provision of HAART may suffice.
If, on the other hand, it is also necessary to increasetive to the norm, this could actually represent a low (not
a high) turnover sytem. It also would be associated with the production of naive T cells, then it is important to
facilitate the function of organs that generate such cellsa decrease in the number of naive T cells, with skewing
in the representation of CD81 T cell populations, and (e.g., bone marrow, thymus, and mucosal immune sys-
tem). Such therapeutic approaches will certainly involvewith restriction of the TCR repertoire.
Differentiating between these alternate viewpoints on the provision of HAART (because damage to these or-
gans is, indeed, HIV-1 mediated). It may in addition re-T cell dynamics goes beyond semantics and raises a
quire maneuvers to replace, regenerate, or otherwise
augment the function of the relevant hematopoietic mi-
croenvironments.
Future Experimental Directions
The above discussion is meant to highlight a key unan-
swered question about kinetics: is the immunopatho-
genesis of HIV-1 infection driven by accelerated de-
struction or by impaired regeneration, or by both?
Answers to this question may be forthcoming from one
of several experimental approaches, as follows.
First, the turnover of T cell subpopulations in HIV-
1±seropositive and HIV-1±seronegative human subjects
may be measured directly. The various models of T cell
kinetics have explicit and experimentally testable pre-
Figure 1. The Kinetic Equation of T Cell Dynamics in HIV-1 Disease:
dictions (Table 2). Resolution of most of these questionsRegenerative Failure and Accelerated Destruction
will require measurement of T cell proliferation and de-
HIV-1 infection may affect cell subpopulations across the hemato-
struction rates in humans. To date, this has been difficultpoietic tree, including multilineage CD41 hematopoietic progenitor
because it has not been possible to label cells metaboli-cells in the bone marrow, T-committed CD41 progenitors in the
thymus, and more mature CD41 T cells in the periphery. In the case cally in humans and to trace precursor±product relation-
of progenitors in the bone marrow, direct or indirect effects may ships directly, as has been done in rodents (Rocha et
result in cell death (McCune and Kaneshima, 1995); in the case of al., 1983; Rocha, 1987; Freitas and Rocha, 1993; Tough
intrathymic T progenitors, direct cytolysis is likely (Su et al., 1995). and Sprent, 1995). Most if not all kinetic measurements
If infection is restricted to circulating CD41 memory T cells, homeo-
have thus been based on a uncertain assumptions. Re-stasis in the system may be maintained by increased production.
cently, however, a stable isotope±mass spectrometricIf hematopoiesis is also curtailed by HIV-1 infection, regenerative
failure may ensue. method for measuring proliferation and destruction
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Table 2. Some Kinetic Predictions of the High Turnover (Accelerated Destruction) and the Low Turnover (Regenerative Failure) Models
of HIV-1 Disease
Accelerated Destruction Regenerative Failure
Viral load High destruction (turnover) rates of memory Low proliferation (turnover) rates of naive
CD41 T cells correlate with high viral load CD41 T cells correlate with high viral
load
Effects of HAART Reduced CD41 T cell destruction rates account Increased CD41 T cell proliferation rates
for increased CD4 number account for increased CD4 number
Nonprogression Lower destruction (turnover) rates in long-term Better maintenance of naive CD41 T cell
nonprogression proliferation (turnover) rates in long-
term nonprogression
Naive T cells Naive CD41 T cell replacement rates are high in Naive CD41 and CD81 T cell replacement
early disease rates are variable in early disease (with
high CD571CD282CD81 replacement
rates)
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